Library licensing deal sends shares in Xenova soaring
Thursday 20 March 1997
The biotech company refused to reveal the financial details of the link- up with Zeneca, which paid pounds 2m for a 4 per cent stake at the time of the float, but Louis Nisbet, chief executive, said it was part of Xenova's "enormous progress" over the past year.
He said the company's QTC libraries, which are derived from plant, fungal and microbial sources, "provide the fastest way of unlocking pharmaceutical products of interest from natural products chemistry". Because of the way they are formatted, these libraries can be shipped to pharmaceuticals companies which can use them to test potential drug targets.
Zeneca will pay an initial licence fee to use the libraries, then milestone fees for every lead it takes up and royalties on any drugs which result from the collaboration. The latest biotech tie-up is the third for Zeneca since last June, following so-called database subscription agreements with Incyte Pharmaceuticals of California and Pharmacopeia of New Jersey.
The news came as Xenova announced a small cut in losses from pounds 7.99m to pounds 7.77m for the year to December, on revenues cut from pounds 1.79m to pounds 1.59m. It started the year with pounds 27.8m net cash, including pounds 21.3m from the placing and is set to pick up pounds 2m under a deal with Warner Lambert shortly.
Separately, Cambridge Antibody Technology announced that its flotation later this month would be priced at 500p, capitalising the group at pounds 109m. The biotechnology company is raising pounds 38m, after expenses, from the placing, with first dealings expected to begin on Tuesday. David Chiswell, chief executive, said the company would use the money to develop CAT's portfolio of antibody-based human therapeutic products.
Also yesterday, Cantab Pharmaceuticals announced its anti-herpes vaccine had been well tolerated in early stage trials. The drug, which formed the centrepiece of a licensing deal with Glaxo Wellcome on Tuesday, was being tested in 24 carriers of the disease in the UK.
- 1 Sofyen Belamouadden murder: The inside story of a crime that horrified Britain
- 2 How to turn off/stop 'seen by' on Facebook: Disable it to make your chats seem less passive aggressive
- 3 Company breaks open Apple Watch to discover what it says is 'planned obsolescence'
- 4 'We're not heroes, just tourists': Swedish police officers on holiday stop vicious assault on New York subway
- 5 Buckingham Palace guard who attacked passers-by in 'most most violent piece of CCTV footage' police officer had seen walks free
Top 20 misconceptions people believe are true
Sofyen Belamouadden murder: The inside story of a crime that horrified Britain
'We're not heroes, just tourists': Swedish police officers on holiday stop vicious assault on New York subway
Nepal earthquake: More than 1,100 killed across four countries and in Mount Everest avalanche
Australian student Tommy Connolly, 23, adopts his pregnant, homeless 17-year-old cousin to give her a chance at 'a better life'
The sickening truth about food banks that the Tories don't want you to know
Katie Hopkins on LBC: Listen to caller taking The Sun columnist to task over migrant comments
Migrant boat disaster: Ukip candidate mocks victims in sickening Twitter post
Nigel Farage wants the BBC to stop making programmes like Doctor Who, Strictly Come Dancing, and Top Gear
Global warming: Scientists say temperatures could rise by 6C by 2100 and call for action ahead of UN meeting in Paris
General Election 2015: Britain would become a 'communist dictatorship' under Ed Miliband and Nicola Sturgeon, claims wife of Michael Gove
iJobs Money & Business
£50000 - £55000 per annum: Ashdown Group: Business Analyst - Financial Service...
£18000 - £23000 per annum + OTE £45K: SThree: At SThree, we like to be differe...
£20000 - £25000 per annum + competitive: SThree: Did you know? SThree is the o...
£22000 - £24000 per annum: Recruitment Genius: This is an opportunity to join ...